piclidenoson
piclidenoson: 2 clinical trials tracked.
piclidenoson evidence translation
What we can confirm
2 tracked trials
No verified listed developer
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about piclidenoson, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trials (2)
An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome
Primary endpoint: 99mTc-DMSA
Interventionalopen5 targetStarted 2026-06Completion 2027-081 site · ItalyCan-Fite BioPharma
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Daily Piclidenoson (CF101) Administered Orally in Subjects With Moderate-to-Severe Plaque Psoriasis
Primary endpoint: Proportion of subjects who achieve a Psoriasis Area and Severity Index (PASI) score response of ≥75% (PASI 75)
InterventionalRandomizedquadruple705 targetStarted 2025-06Completion 2028-06Can-Fite BioPharma